Rchr
J-GLOBAL ID:202101011045366010   Update date: Feb. 01, 2024

Matsushima Saki

Matsushima Saki
Affiliation and department:
Research field  (2): Virology ,  Molecular biology
Research keywords  (2): アデノウイルスベクター ,  遺伝子治療
Research theme for competitive and other funds  (8):
  • 2021 - 2026 BBB通過型GALC発現AAVベクターはクラッベ病マウスの寿命延長効果を持つか
  • 2022 - 2026 Pompe病の根治を目指した新規遺伝子治療法の開発研究
  • 2021 - 2024 ヒト型受容体介在性トランスサイトーシスを利用したライソゾーム病遺伝子治療法の開発
  • 2015 - 2018 Search for new potential drug targets for Hepatitis B virus genome replication based on chemical biology
  • 2015 - 2017 ウイルスベクターによる高感度HBV複製検出系を用いたcccDNA生成機序の解析
Show all
Papers (23):
  • Sayaka Nagamoto, Miyuki Agawa, Emi Tsuchitani, Kazunori Akimoto, Saki Kondo Matsushima, Yumi Kanegae. Short term but highly efficient Cas9 expression mediated by excisional system using adenovirus vector and Cre. Scientific reports. 2021. 11. 1. 24369-24369
  • Manabu Yamasaki, Norie Matsuda, Kazuaki Matoba, Saki Kondo, Yumi Kanegae, Izumu Saito, Akio Nomoto. Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly. Virus research. 2021. 306. 198565-198565
  • 角皆 季樹, 大橋 十也, 嶋田 洋太, 樋口 孝, 木村 文香, 松島 小貴, 渡部 文子, 小林 博司. 造血幹細胞を標的としたレンチウイルスベクターを用いたGM1ガングリオシドーシスの遺伝子治療法の開発. 東京慈恵会医科大学雑誌. 2021. 136. 6. 136-137
  • Malgorzata Gozdecka, Eshwar Meduri, Milena Mazan, Konstantinos Tzelepis, Monika Dudek, Andrew J Knights, Mercedes Pardo, Lu Yu, Jyoti S Choudhary, Emmanouil Metzakopian, et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nature genetics. 2018. 50. 6. 883-894
  • Mariko Suzuki, Saki Kondo, Manabu Yamasaki, Norie Matsuda, Akio Nomoto, Tetsuro Suzuki, Izumu Saito, Yumi Kanegae. Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit. Scientific reports. 2017. 7. 41851-41851
more...
MISC (2):
  • Saki Kondo, Yumi Kanegae, Nic Jones, Izumu Saito. A role of microRNAs for sensitization to cisplatin in ovarian cancer cell lines. HUMAN GENE THERAPY. 2012. 23. 10. A96-A96
  • Saki Kondo, Miho Terashima, Pei Zheng, Yumi Kanegae, Izumu Saito. Construction of "Humanized" FLP Recombinases Aiming for Efficient Generation of Helper-Dependent Adenovirus Vector. MOLECULAR THERAPY. 2009. 17. S45-S45
Lectures and oral presentations  (3):
  • Gene therapy for GM1 gangliosidosis mediated by AAV vector carrying BBB-penetrable enzyme
    (American Society of Gene and Cell Therapy 2023)
  • Gene therapy for GM1 gangliosidosis mediated by AAV vector carrying BBB-penetrable enzyme
    (2022)
  • Gene therapy for GM1 gangliosidosis mediated by AAV vector carrying BBB-penetrable enzyme
    (2022)
Education (2):
  • 2003 - 2007 The University of Tokyo Graduate School of Medicine
  • 1996 - 2000 Kitasato University School of Pharmaceutical Sciences
Professional career (1):
  • Ph.D. (The University of Tokyo)
Work history (5):
  • 2021/04 - 現在 Jikei University
  • 2020/04 - 2021/03 Jikei University
  • 2007/04 - 2016/03 東京大学医科学研究所 遺伝子解析施設 助教
  • 2010/04 - 2012/03 Paterson Institute for Cancer Research Cell Signaling
  • 2004/04 - 2007/03 日本学術振興会 特別研究員(DC2)
Association Membership(s) (2):
日本先天代謝異常学会 ,  日本遺伝子細胞治療学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page